相关实验视频
Updated: Feb 8, 2026
07:30
Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
4.4K
一个mycophenolate的药理动力学研究,带来了对移植接受者的肠肝循环的新见解
Moataz E Mohamed1, Abdelrahman Saqr1, Guillaume Onyeaghala2
1Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, 7-151 Weaver-Densford Hall, 308 Harvard Street SE, Minneapolis, MN, 55455, USA.
Clinical pharmacokinetics
|February 6, 2026
概括
肠肝循环 (EHR) 模式,而不是百分比,在移植患者中显著影响酸 (MPA) 水平. 了解二次峰值对于优化用甲酸莫菲蒂尔 (MMF) 进行免疫抑制至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 移植医学 移植医学 移植医学
- 临床化学 临床化学
背景情况:
- 基酸 (MPA) 药理动力学是复杂的,受肠肝循环 (EHR) 的影响.
- 优化免疫抑制需要对MPA暴露和EHR模式有更深入的了解.
- 本研究全面评估MPA及其代谢物,重点关注EHR特征.
研究的目的:
- 在脏移植接受者中全面评估MPA和代谢物的药理动力学.
- 调查肠肝循环 (EHR) 和其模式对MPA暴露的影响.
- 确定EHR,二次峰值和达到治疗MPA水平之间的关联.
主要方法:
- 84名接受Mycophenolate Mofetil (MMF) 和Tacrolimus治疗的移植患者进行了密集的MPA药理动力学评估.
- 确定MPA和代谢物的药理动力学,EHR百分比和二次峰数.
- 研究了EHR,二次峰值和MPA治疗范围的成就之间的关联.
主要成果:
- 在AUC0-12,低谷度和EHR%中,MPA的药理动力学显示出很高的变化.
- 在EHR%和MPA AUC0-12或谷部水平之间没有发现显著的关联.
- MPA AUC0-12和低谷与二次峰值的数量 (0,1,或≥2) 有显著的关联.
结论:
- MPA EHR百分比与MPA AUC0-12或低谷值没有相关性.
- 三种不同的MPA二次峰值模式 (0,1,或≥2) 显著影响了MPA暴露.
- 需要进一步的研究来将MPA EHR措施与临床结果联系起来.
相关概念视频
01:28Kidney Transplant I: Introduction
492
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
492
01:26Kidney Transplant II: Surgical Procedure
430
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
430
01:16Kidney Transplant III: Nursing Management
402
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
402
01:28Imaging Studies I: Kidney, Ureter, and Bladder Studies
374
Kidney, Ureter, and Bladder (KUB) StudiesKidney, Ureter, and Bladder (KUB) studies are standard diagnostic imaging procedures used to assess the anatomy of the urinary system. They are commonly utilized for patients experiencing abdominal pain or urinary symptoms. By using a simple X-ray of the abdomen, KUB studies can reveal structural and pathological abnormalities within the kidneys, ureters, and bladder. These studies are particularly valuable in diagnosing kidney stones, urinary...
374
01:45Kidney Structure
75.4K
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
75.4K
01:17Hepatic Drug Excretion: Enterohepatic Cycling
2.8K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
2.8K